The purpose of this study was to screen for high-risk factors leading to the early recurrence
of hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA) and to construct a …

Aim: To evaluate changes in liver function parameters and risk factors 1 year after
percutaneous radiofrequency ablation (RFA) therapy in patients with hepatocellular …

The prognostic significance of various systemic inflammation‐based markers has been
explored in different cancers after surgery. This study aimed to investigate whether these …

Background/Aim: Hepatocellular carcinoma (HCC) mainly develops in the damaged liver
from hepatitis C virus (HCV) or hepatitis B virus (HBV) infection in Japan. On the other hand …

Background Post-treatment alpha-fetoprotein (AFP) response has been reported to be
associated with prognosis of hepatocellular carcinoma (HCC). We aimed to determine …

Results There was no statistical correlation between DCP level measured by MU-3 antibody
and DCP ratio. Clinical stage, tumor type, portal tumor thrombus and DCP were independent …

An efficient serum marker for hepatocellular carcinoma (HCC) is currently lacking and
requires intensive exploration. We aimed to evaluate the performance of des-gamma …

Purpose To construct a nomogram with the albumin-bilirubin (ALBI) grade to assess the long-
term outcomes of patients with early-stage hepatocellular carcinoma (HCC) after …

Aim Survival estimates are commonly reported as survival from the first observation, but
future survival probability changes based on the survival time already accumulated after …

Purpose Although alpha-fetoprotein (AFP) and des-gamma-carboxyprothrombin (DCP) have
a certain predictive ability for the prognosis of hepatocellular carcinoma (HCC), there are still …